Raymond Anderson

Insider Reports History

Entity
Individual
Location
C/O Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette, IL
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raymond Anderson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Director Common Stock 26.9K $9.14K $0.34 Dec 31, 2023 Direct
Monopar Therapeutics Director Restricted Stock Units 0 $0.34 Dec 31, 2023 Direct

Insider Reports Filed by Raymond Anderson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNPR Monopar Therapeutics Dec 31, 2023 2 $0 4 Jan 3, 2024 Director
MNPR Monopar Therapeutics Sep 30, 2023 2 $0 4 Oct 3, 2023 Director
MNPR Monopar Therapeutics Jun 30, 2023 2 $0 4 Jul 3, 2023 Director
MNPR Monopar Therapeutics Mar 31, 2023 2 $0 4 Apr 4, 2023 Director
MNPR Monopar Therapeutics Feb 1, 2023 2 $0 4 Feb 3, 2023 Director
MNPR Monopar Therapeutics Dec 31, 2022 2 $0 4 Jan 3, 2023 Director
MNPR Monopar Therapeutics Sep 30, 2022 2 $0 4 Oct 3, 2022 Director
MNPR Monopar Therapeutics Jun 30, 2022 2 $0 4 Jul 1, 2022 Director
MNPR Monopar Therapeutics Mar 31, 2022 2 $0 4 Apr 1, 2022 Director
MNPR Monopar Therapeutics Feb 2, 2022 2 $0 4 Feb 4, 2022 Director
MNPR Monopar Therapeutics Dec 31, 2021 2 $0 4 Jan 4, 2022 Director
MNPR Monopar Therapeutics Sep 30, 2021 2 $0 4 Oct 1, 2021 Director
MNPR Monopar Therapeutics Jun 30, 2021 2 $0 4 Jul 2, 2021 Director